Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.098 | 0.04 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.06 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |